· Weekly signal · AXSM
Axsome Therapeutics Inc (AXSM) pushes 12-week advance to 62.6%
The CNS-focused biotech remains in an active trend, but confirmation is measured rather than broad-based.
Axsome Therapeutics Inc (AXSM) finished the latest weekly period at 255.17 USD, adding 9.8% for the week and 12.1% over four weeks in weekly market data.
The 52-week weekly price path shows the advance extending, while volume was close to normal at 3.44 million shares versus a 13-week average of 3.48 million. Market Dynamics showed positive confirmation at 1.15, while Relative Strength at 41.2 left the setup short of a stronger momentum reading.